Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Neurology, neuroimmunology & neuroinflammation, 10, 4, 13 S.
- Event
-
Veröffentlichung
- (where)
-
Bochum
- (who)
-
Ruhr-Universität Bochum
- (when)
-
2023
- Creator
-
Hellwig, Kerstin
Tokic, Marianne
Thiel, Sandra
Hemat, Spalmai
Timmesfeld, Nina
Ciplea, Andrea I.
Gold, Ralf
Langer-Gould, Annette
- URN
-
urn:nbn:de:hbz:294-104870
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hellwig, Kerstin
- Tokic, Marianne
- Thiel, Sandra
- Hemat, Spalmai
- Timmesfeld, Nina
- Ciplea, Andrea I.
- Gold, Ralf
- Langer-Gould, Annette
- Ruhr-Universität Bochum
Time of origin
- 2023
Other Objects (12)
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Multiple Sclerosis Relapses Following Cessation of Fingolimod
Dietary fatty acids and susceptibility to multiple sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
Fingolimod for irradiation-induced neurodegeneration
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Genomic NGFBvariation and multiple sclerosis in a case control study
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Multiple Sclerosis Relapses Following Cessation of Fingolimod
Dietary fatty acids and susceptibility to multiple sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
Fingolimod for irradiation-induced neurodegeneration
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Genomic NGFBvariation and multiple sclerosis in a case control study
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Multiple Sclerosis Relapses Following Cessation of Fingolimod
Dietary fatty acids and susceptibility to multiple sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
Fingolimod for irradiation-induced neurodegeneration
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy